Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genomic landscape of treatment refractory metastatic colorectal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder

    Research output: Contribution to journalLetterResearchpeer-review

  4. Management of late adverse effects after chemoradiation for anal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.

AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.

Original languageEnglish
JournalActa Oncologica
Volume60
Issue number7
Pages (from-to)931-941
Number of pages11
ISSN0284-186X
DOIs
Publication statusPublished - Jul 2021

    Research areas

  • Gastrointestinal Neoplasms, Humans, Intestinal Neoplasms/diagnosis, Neuroendocrine Tumors/diagnosis, Pancreatic Neoplasms/diagnosis, Stomach Neoplasms/diagnosis

ID: 68601600